1. FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

Create Thread

A moderated forum to discuss general whistleblower/fraud issues with attorneys specializing in this area.


(CustomImgCaptcha By Surrey Forum)


Multiple tags may be separated by commas.

By submitting this post, you agree to be bound to the terms and conditions of our site.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.